Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Impact of second-line combination chemotherapy on post-progression survival in metastatic and recurrent pancreatic cancer
Takafumi Mie
Masato Ozaka
Takeshi Okamoto
Tsuyoshi Takeda
Yoichiro Sato
Tatsuki Hirai
Takahiro Ishitsuka
Yuri Maegawa
Takaaki Furukawa
Yukari Suzuki
Takashi Sasaki
Naoki Sasahira
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1007/s10147-025-02796-0
Jun 11, 2025
Version published to 10.21203/rs.3.rs-5965079/v1 on Research Square
Apr 30, 2025
Related articles
Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: A single-arm, phase 2 clinical trial
This article has 11 authors:
Ting Han
Meng Zhuo
Xinyi Zheng
Xiuqi Wu
Feng Jiao
Jiujie Cui
Tao Wang
Xiaoxia Qiu
Yingjie Su
Xiaolin Lin
Xiuying Xiao
Anlotinib Plus Camrelizumab And Chemotherapy As First-Line Treatment In Patients With Advanced Esophageal Squamous Cell Carcinoma
This article has 7 authors:
Mingfang Xu
Yu Pu
Yuzhu Jiang
Yingda Liu
Yan Feng
Xiaodong Zhao
Mengxia Li
Multimodality Approach for Locally Advanced Lung Cancer: When Is Surgery Most Beneficial?
This article has 11 authors:
Riad Amin Abdeljalil
Ahed Al-odwan
Sakhr Alshwayyat
Leen Osama Nemrawi
Taher Abu Hejleh
Kamal Alrabi
Sameer Yaser
Husam Abu Jazar
Jamal Khader
Anoud Al-Nsour
Husam Al-Haddad
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up